Language skills in a child with leber hereditary optic neuropathy following intrathecal chemotherapy for acute lymphoblastic leukemia

Pediatric Hematology and Oncology

Volumn 27, Issue 8, 2010, Pages 626-635

  Lewis, Fiona M ^a   Coman, David J ^a,b   Murdoch, Bruce E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

ALL; Chemotherapy; Genetics; Late effects; Neuropsychology

Indexed keywords

CYTARABINE; HYDROCORTISONE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BRAIN DAMAGE; CANCER CHEMOTHERAPY; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FAMILY HISTORY; GENE MUTATION; HUMAN; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; IMMUNOSUPPRESSIVE TREATMENT; LANGUAGE ABILITY; LANGUAGE DEVELOPMENT; LEBER HEREDITARY OPTIC NEUROPATHY; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOENCEPHALOPATHY; MAINTENANCE DRUG DOSE; MALE; MITOCHONDRIAL GENE; MTMD4 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; SCHOOL CHILD; SCORING SYSTEM; SPEECH AND LANGUAGE ASSESSMENT; TREATMENT DURATION; WHITE MATTER; WHOLE BODY RADIATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; HUMANS; INJECTIONS, SPINAL; LANGUAGE DEVELOPMENT DISORDERS; MAGNETIC RESONANCE IMAGING; MALE; OPTIC ATROPHY, HEREDITARY, LEBER; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 77958041968     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2010.503340     Document Type: Article

References (43)

1. Yu-Wai-Man P, Griffiths PG, Hudson G, et al Inherited mitochondrial optic neuropathies. J Med Genet. 2009;46:145-158.
2. Kirkman MA, Korsten A, Leonhardt M, et al Quality of life in patients with leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2009;50:3112-3115.
3. Mackey DA, Buttery RG. Leber hereditary optic neuropathy in Australia. Aust N Z J Ophthalmol. 1992;20:177-184.
4. Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23:53-89.
5. Kov́acs GG, Höftberger R, Majt́enyi K, et al Neuropathology of white matter disease in Leber's hereditary optic neuropathy. Brain. 2005;128:35-41.
6. Küker W, Weir A, Quaghebeur G, et al Whitematter changes in Leber's hereditary optic neuropathy: MRI findings. Eur J Neurol. 2007;14:591-593.
7. Perez F, Anne O, Debruxelles S, et al Leber's optic neuropathy associated with disseminated white matter disease: a case report and review. Clin Neurol Neurosurg. 2009;111:83-86.
8. Mackey DA, Fingert JH, Luzhansky JZ, et al Leber's hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus. Eye. 2003;17:312-317.
9. Zanssen S, Buse G. Successful chemotherapy in a male patient with malignant lymphoma and Leber's hereditary optic neuropathy (LHON). Am J Hematol. 2003;72:263-266.
10. Bhatia S, Meadows AT. Long-term follow-up of childhood cancer survivors: future directions for clinical care and research. Pediatr Blood Cancer. 2006;46:143-148.
11. Alfassi M. Reading to learn: effects of combined strategy instruction on high school students. J Educ Res. 2004;97:171-184.
12. Asher SR, Gazelle H. Loneliness, peer relations, and language disorder in childhood. Top Lang Disord. 1999;19:16-33.
13. Gallagher TM. Interrelationships among children's language, behavior, and emotional problems. Top Lang Disord. 1999;19:1-15.
14. Buttsworth DL, Murdoch BE, Ozanne AE. Acute lymphoblastic leukaemia: language deficits in children post-treatment. Disabil Rehabil. 1993;15:67-75.
15. Jackel CA, Murdoch BE, Ozanne AE, et al Language abilities of children treated for acute lymphoblastic leukaemia: preliminary findings. Aphasiology. 1990;4:45-53.
16. Lewis FM, Murdoch BE, Barwood C, et al Language outcomes following treatment for acute lymphoblastic leukaemia with CNS chemotherapy: a two-year follow-up study. Asia Pac J Speech Lang Hear. 2010;13:51-60.
17. Semel E, Wiig EH, Secord WA. Clinical Evaluation of Language Fundamentals. 4th ed. San Antonio, TX: Harcourt Assessment; 2003.
18. Dunn LM, Dunn LM. Peabody Picture Vocabulary Test. 3rd ed. Circle Pines, MN: American Guidance Service; 1997.
19. Fisher JP, Glenister JM. The Hundred Pictures Naming Test. Melbourne, Australia: ACER; 1992.
20. Bowers L, Huisingh R, LoGiudice C. Test of Problem Solving 3: Elementary. East Moline, IL: LinguiSystems; 2005.
21. Wiig EH, Secord WA. Test of Language Competence - Expanded Edition. New York: The Psychological Corporation; 1989.
22. Anderson V. Childhood white matter injuries: What are the issues? Dev Neuropsychol. 2007;32:619-623.
23. Carey ME, Haut MW, Reminger SL, et al Reduced frontal white matter volume in longterm childhood leukemia survivors: a voxel-based morphometry study. AJNR Am J Neuroradiol. 2008;29:792-797.
24. Bernal B, Ardila A. The role of the arcuate fasciculus in conduction aphasia. Brain. 2009;132:2309-2316.
25. Khong P-L, Leung LHT, Fung ASM, et al White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. J Clin Oncol. 2006;24:884-890.
26. Murdoch BE, Lethlean JB. Language disorders in multiple sclerosis. In: Murdoch BE, Theodoros DG, eds. Speech and Language Disorders in Multiple Sclerosis. London: Whurr Publishers; 2000: 109-130.
27. Ikeda A, Ikeda T, Ikeda N, et al Leber's hereditary optic neuropathy precipitated by ethambutol. Jpn J Ophthalmol. 2006;50:280-283.
28. Aarsen FK, Paquier PF, Arts WF, et al Cognitive deficits and predictors 3 years after diagnosis of a pilocytic astrocytoma in childhood. J Clin Oncol. 2009;27:3526-3532.
29. Dietrich J, Monje M, Wefel J, et al Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist. 2008;13:1285-1295.
30. von der Weid N. Late effects in long-term survivors of ALL in childhood: experiences from the SPOG late effects study. Swiss Med Wkly. 2001;131:180-187.
31. Alajouanine T, Lhermitte F. Aquired aphasia in children. Brain. 1965;88:653-662.
32. Anderson V, Godber T, Smibert E, EkertH.Neurobehavioural sequelae following cranial irradiation and chemotherapy in children: an analysis of risk factors. Pediatr Rehabil. 1997;1:63-76.
33. Anderson V, Northam E, Hendy J, et al. Developmental Neuropsychology: A Clinical Approach. Hove, East Sussex: Psychology Press; 2001.
34. Westby CE. Learning to talk-talking to learn: oral-literate language differences. In: Simon CS, ed. Communication Skills and Classroom Success. London: Taylor and Francis; 1985:181-213.
35. Brìere M-E, Scott JG, McNall-Knapp RY, et al Cognitive outcome in pediatric brain tumor survivors: delayed attention deficit at long-term follow-up. Pediatr Blood Cancer. 2008;50:337-340.
36. Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol. 2000;15:603-630.
37. Raymond-Speden E, Tripp G, Lawrence B, et al Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia. J Pediatr Psychol. 2000;25:59-68.
38. von der Weid N, Mosimann I, Hirt A, et al Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: age- and sex-related differences. Eur J Cancer. 2003;39:359-365.
39. Nippold MA. Later Language Development: School-age Children, Adolescents, and Young Adults. 3rd ed. Austin, TX: Pro-Ed; 2007.
40. Cooper DC, Anderson-Inman L. Language and socialization. In: Nippold MA, ed. Later Language Development: Ages 9 Through 19. Austin, TX: Pro-Ed; 1988:225-245.
41. Nelson NW. Childhood Language Disorders in Context: Infancy Through Adolescence. New York: Merrill/ Mc Millan; 1993.
42. Nippold MA. Figurative language. In: Nippold MA, ed. Later Language Development: Ages 9 Through 19. Austin, TX: Pro-Ed; 1988:179-210.
43. Anderson PJ,Wood SJ, Francis DE, et al Are neuropsychological impairments in children with earlytreated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels? Dev Neuropsychol. 2007;32:645-668.